Nearly 4 years since the first messenger RNA (mRNA) COVID-19 vaccines were developed, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is evolving more quickly than tailored ...

The White House hosted a forum on the next generation of COVID-19 vaccines as pharmaceutical companies plan on releasing updated shots this fall. The forum was held on Tuesday as COVID-19 cases grow ...

Moderna said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older, as well as in individuals aged 12 to 64 with at least one underlying ...

BioNTech SE BNTX has filed a patent infringement lawsuit against Moderna Inc. MRNA, alleging that Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, relies on proprietary technology developed and ...

When historians look back at the social consequences of the COVID pandemic, they will likely focus on public health failures, ...

In November 2024, the Data Safety Monitoring Board (DSMB) for the ongoing Phase 2 clinical trial of GEO-CM04S1 as a booster vaccine for patients with CLL conducted an interim data review of the study.

SILVER SPRING, Md. — The Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since ...